会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Functionalization of silk material by avidin-biotin interaction
    • 丝素材料通过抗生物素蛋白 - 生物素相互作用进行功能化
    • US08293486B2
    • 2012-10-23
    • US13381687
    • 2010-07-20
    • David L. KaplanXiaoqin WangMonica A. Serban
    • David L. KaplanXiaoqin WangMonica A. Serban
    • G01N33/53C07K1/00
    • C07K14/43586A61K47/64A61K47/6903A61K47/6921
    • The present invention provides for compositions and methods of linking silk fibroin to active agents through the specific interaction between avidin and biotin, providing for functionalization of silk-based protein biomaterials. An avidin- or biotin-modified silk is a biomaterial platform for functionalization with a variety of correspondingly linked active agents, such as antibodies and growth factors. A variety of functionalized silk materials, such as silk hydrogel, silk micro/nanoparticles and silk films, can be prepared by the methods of the present invention. The functionalization strategies of the present invention are relatively easy, fast and feasible, and are thus useful in many biomedical applications.
    • 本发明提供通过抗生物素蛋白和生物素之间的特异性相互作用将丝素蛋白与活性剂连接的组合物和方法,提供了基于丝的蛋白质生物材料的功能化。 抗生物素蛋白或生物素修饰的丝是用于与多种相应连接的活性剂如抗体和生长因子进行功能化的生物材料平台。 可以通过本发明的方法制备各种功能性丝绸材料,例如丝素水凝胶,丝微/纳米颗粒和丝膜。 本发明的功能化策略相对容易,快速和可行,因此在许多生物医学应用中是有用的。
    • 10. 发明申请
    • SILK NANOSPHERES AND MICROSPHERES AND METHODS OF MAKING SAME
    • 丝素纳米微粒和微球及其制备方法
    • US20120187591A1
    • 2012-07-26
    • US13496227
    • 2010-09-29
    • Xiaoqin WangDavid L. Kaplan
    • Xiaoqin WangDavid L. Kaplan
    • B29B9/16B29B9/00A61K9/50C07K14/00B82Y5/00B82Y30/00
    • A61K9/5169A61K9/14A61K9/1605A61K9/1647A61K9/5052A61K9/5089A61K9/5192A61K31/352Y10T428/2982
    • The present invention provides for methods of preparing silk nanoparticles and microparticles, methods of encapsulating an active agent into the silk nano- and microparticles and compositions comprising these silk particles. In particular, the silk spheres are prepared from phase separation of silk and polyvinyl alcohol (PVA), without exposure to an organic solvent. The method employs a chemical, PVA, which is an FDA-approved ingredient in drug formulations. Different parameters can be adjusted to control the size and shape of the silk spheres during the fabrication process. The silk particle compositions of the present invention may also encapsulate active agents or chemicals. Such compositions allow the active agents to be controllably and sustainably released to the target organs or tissues. The silk composition entrapping active agents also provides for a long-term storage medium for the active agents so entrapped. The silk nano- and microparticles of the present invention are thus suitable for a variety of biomedical and pharmaceutical applications, such as drug delivery or tissue engineering.
    • 本发明提供了制备丝纳米颗粒和微粒的方法,将活性剂包封在丝纳米和微粒中的方法和包含这些丝颗粒的组合物。 特别地,丝球是通过丝和聚乙烯醇(PVA)的相分离制备的,而不暴露于有机溶剂。 该方法采用化学品PVA,它是FDA批准的药物制剂成分。 可以调整不同的参数,以在制造过程中控制丝球的尺寸和形状。 本发明的丝粒组合物也可以包封活性剂或化学物质。 这样的组合物允许活性剂可控地和可持续地释放到靶器官或组织。 包埋活性剂的丝绸组合物还为被捕获的活性剂提供长期的储存介质。 因此,本发明的丝素纳米颗粒和微粒子适用于各种生物医学和药物应用,例如药物递送或组织工程。